Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Merck & Co
(NY:
MRK
)
80.93
-1.46 (-1.77%)
Official Closing Price
Updated: 5:00 PM EDT, Jul 3, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Merck & Co
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Trump's 'Big, Beautiful Bill' Hands $5 Billion Win To Big Pharma: Report
July 04, 2025
Trump's $3.3 trillion domestic agenda bill, passed by the House on Thursday, includes a significant victory for pharmaceutical companies .
Via
Benzinga
Topics
Government
2 S&P 500 Stocks with Promising Prospects and 1 to Question
July 04, 2025
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth,...
Via
StockStory
Topics
Stocks
Uncover the latest developments among S&P500 stocks in today's session.
July 03, 2025
Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Thursday.
Via
Chartmill
AstraZeneca In $15B Talks For Drug That Could Upend Lung Cancer Treatment
July 03, 2025
Via
Benzinga
What's going on in today's session: S&P500 gap up and gap down stocks
July 03, 2025
Wondering which stocks are making significant price gaps? Explore the S&P500 index on Thursday to find the gap up and gap down stocks in today's session.
Via
Chartmill
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
July 03, 2025
Via
Benzinga
Merck's Hypertension Drug On FDA Fast Track For Label Expansion
July 02, 2025
Merck's Winrevair gains FDA priority review for PAH label update after ZENITH trial shows major reduction in serious events and strong clinical impact.
Via
Benzinga
FDA Grants Priority Review for WINREVAIR™ (sotatercept-csrk) to Update Label Based on Results From ZENITH Trial
July 02, 2025
From
Merck & Co., Inc.
Via
Business Wire
MERCK & CO. INC. (NYSE:MRK) – A Strong Value Candidate in Healthcare
July 02, 2025
MERCK & CO. (NYSE:MRK) is an undervalued pharmaceutical stock with strong profitability, a healthy balance sheet, and a reliable dividend, making it a candidate for value investors.
Via
Chartmill
Dogs Of The Dow: How You Can Get Dividend Stocks With Yields Up To 6.3%
July 01, 2025
The Dow Jones Industrial Average stocks average a 2% dividend yield through the first six months of 2025. Here are the top yields.
Via
Benzinga
Topics
Stocks
Dow Jones 2025 First Half Scoreboard: Top 10 Winners, Losers — Where Do Nvidia, Apple Stock Rank?
July 01, 2025
The Dow Jones Industrial Average was up around 4% in the first half of 2025 with a large majority of the 30 stocks positive.
Via
Benzinga
Topics
Stocks
Merck to Hold Second-Quarter 2025 Sales and Earnings Conference Call July 29
July 01, 2025
From
Merck & Co., Inc.
Via
Business Wire
HDV Is a Popular Dividend ETF for Passive Income. But Is It the Best?
July 01, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
ETFs
Stocks
Can Protagonist Take On Eli Lilly's Next-Generation Obesity Treatment?
June 30, 2025
The company announced a new drug that uses the same mechanism as Eli Lilly's retatrutide.
Via
Investor's Business Daily
Peering Into Merck & Co's Recent Short Interest
June 30, 2025
Via
Benzinga
1 Profitable Stock to Consider Right Now and 2 to Think Twice About
June 30, 2025
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.
Via
StockStory
3 Absurdly Cheap Stocks Ready for a Breakout
June 28, 2025
All three stocks are poised to go higher.
Via
The Motley Fool
RFK Jr's CDC Panel Recommends Merck's RSV Shot For Infants
June 27, 2025
CDC panel backs Merck's Enflonsia for RSV prevention in infants; FDA-approved therapy reduced hospitalizations by 84% in clinical trials.
Via
Benzinga
CDC Vaccine Panel Overhauled by RFK Jr. Votes To Drop Mercury Preservative, Critics Sound Alarm
June 26, 2025
The panel also voted to recommend Merck’s RSV antibody drug Enflonsia for newborns whose mothers didn’t receive prenatal protection.
Via
Stocktwits
5 Biotech Stocks with Highly Anticipated Pending Results
June 26, 2025
Via
Stocktwits
Topics
Intellectual Property
Elanco Animal Health Gets Its Bite Back, Pipeline Efforts Earn Praise
June 26, 2025
Elanco upgraded to Outperform by William Blair as pipeline gains traction and EMA backs Zenrelia ahead of expected Q3 approval.
Via
Benzinga
ACIP Recommends Use of Merck’s ENFLONSIA™ (clesrovimab-cfor) for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants Younger than 8 Months of Age Born During or Entering Their First RSV Season
June 26, 2025
From
Merck & Co., Inc.
Via
Business Wire
2 Stocks Too Cheap to Ignore at These Prices
June 26, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
Lawsuit
RFK Jr. Overhauls CDC Vaccine Panel, Sparking Expert Backlash, Boycott From Top Medical Group
June 26, 2025
Health Secretary Robert F. Kennedy Jr.'s newly reconstituted vaccine advisory panel is facing criticism from medical experts.
Via
Benzinga
Merck to Hold Investor Event to Highlight Advancing Research Pipeline for HIV Treatment and Prevention
June 24, 2025
From
Merck & Co., Inc.
Via
Business Wire
Merck's Hypertension Drug Cuts Clinical Worsening Risk In Over 70% Of Patients On Double Background Therapy
June 23, 2025
Merck's Winrevair reduced clinical worsening in PAH patients in the Phase 3 HYPERION trial, building on prior positive study outcomes.
Via
Benzinga
Merck Announces Phase 3 HYPERION Study of WINREVAIR™ (sotatercept-csrk) Met Primary Endpoint in Recently Diagnosed Adults with Pulmonary Arterial Hypertension (PAH)
June 23, 2025
From
Merck & Co., Inc.
Via
Business Wire
Obesity Drugs Help With Weight Loss But Are Adding Fat Elsewhere
June 20, 2025
The U.S. trade deficit with Ireland has surged as $36 billion in hormone shipments for weight-loss and diabetes drugs were flown in to meet demand and avoid tariffs.
Via
Benzinga
Mark Cuban Corrects Elizabeth Warren As She Slams JNJ, PFE For Higher Prices And Zero Taxes On Big Pharma: 'PBMs Corrupt Healthcare'
June 20, 2025
A debate over the healthcare system erupted on X, pitting Mark Cuban against Elizabeth Warren over the root causes of soaring drug prices.
Via
Benzinga
2 Reasons to Watch MRK and 1 to Stay Cautious
June 19, 2025
Shareholders of Merck would probably like to forget the past six months even happened. The stock dropped 20.3% and now trades at $79.30. This might have investors contemplating their next move.
Via
StockStory
Topics
Supply Chain
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.